Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
2020 2
2023 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations on data sharing in HIV drug resistance research.
Inzaule SC, Siedner MJ, Little SJ, Avila-Rios S, Ayitewala A, Bosch RJ, Calvez V, Ceccherini-Silberstein F, Charpentier C, Descamps D, Eshleman SH, Fokam J, Frenkel LM, Gupta RK, Ioannidis JPA, Kaleebu P, Kantor R, Kassaye SG, Kosakovsky Pond SL, Kouamou V, Kouyos RD, Kuritzkes DR, Lessells R, Marcelin AG, Mbuagbaw L, Minalga B, Ndembi N, Neher RA, Paredes R, Pillay D, Raizes EG, Rhee SY, Richman DD, Ruxrungtham K, Sabeti PC, Schapiro JM, Sirivichayakul S, Steegen K, Sugiura W, van Zyl GU, Vandamme AM, Wensing AMJ, Wertheim JO, Gunthard HF, Jordan MR, Shafer RW. Inzaule SC, et al. Among authors: raizes eg. PLoS Med. 2023 Sep 22;20(9):e1004293. doi: 10.1371/journal.pmed.1004293. eCollection 2023 Sep. PLoS Med. 2023. PMID: 37738247 Free PMC article.
High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia.
Jordan MR, Hamunime N, Bikinesi L, Sawadogo S, Agolory S, Shiningavamwe AN, Negussie T, Fisher-Walker CL, Raizes EG, Mutenda N, Hunter CJ, Dean N, Steegen K, Kana V, Carmona S, Yang C, Tang AM, Parkin N, Hong SY. Jordan MR, et al. Among authors: raizes eg. Medicine (Baltimore). 2020 Sep 11;99(37):e21661. doi: 10.1097/MD.0000000000021661. Medicine (Baltimore). 2020. PMID: 32925712 Free PMC article.
Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study.
Marc JB, McCarthy C, Wallis CL, Kityo C, Hughes MD, Godfrey C, Shah NS, Parikh UM, Maartens G, Kanyike F, Van Schalkwyk M, Kihumuro RB, Asiimwe P, Tsikhutsu I, Munyanga C, Some FF, Joseph Y, Flowers T, Mohapi L, Samaneka WP, Mponda K, Rassool MS, Pierre S, Woolley E, Manabe YC, Mellors JW, Flexner C, Koenig SP, Mngqibisa R; ACTG A5381–Hakim Study Team. Marc JB, et al. Lancet HIV. 2025 Dec;12(12):e836-e849. doi: 10.1016/S2352-3018(25)00162-6. Lancet HIV. 2025. PMID: 41314742